Cointime

Pulmotect

company

About

Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.

  • 1 - 10

Highlights

Total Funding Amount
$13M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$1M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Pulmotect is a biopharma company that develops products that boost the innate immune system to protect against a wide range of lung infections. Its technology stimulates the body’s natural defenses to provide safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague).

It was founded in 2007 and is headquartered in Houston, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$13M
Pulmotect has raised a total of $13M in funding over 2 rounds. Their latest funding was raised on Apr 4, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 4, 2018 Series B $12M 1 — — Detail
Apr 5, 2016 Grant $1M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Pulmotect is funded by 2 investors. Aquinas and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
Aquinas — Series B
National Institutes of Health — Grant
Cointime
Chủ Đề
Công Ty